Cocrystal Pharma, Inc. - Common Stock — Filings & Documents (NASDAQ:COCP) — Page 17 | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

2017

Current report, Q1 FY2017

Cocrystal Pharma, Inc. current report, Q1 FY2017

2016

Current report, Q4 FY2016

Cocrystal Pharma, Inc. current report, Q4 FY2016

Current report, Q3 FY2016

Cocrystal Pharma, Inc. current report, Q3 FY2016

Current report, Q3 FY2016

Cocrystal Pharma, Inc. current report, Q3 FY2016

Current report, Q3 FY2016

Cocrystal Pharma, Inc. current report, Q3 FY2016

Current report, Q2 FY2016

Cocrystal Pharma, Inc. current report, Q2 FY2016

Current report, Q2 FY2016

Cocrystal Pharma, Inc. current report, Q2 FY2016

Current report, Q1 FY2016

Cocrystal Pharma, Inc. current report, Q1 FY2016

2015

Current report, Q4 FY2015

Cocrystal Pharma, Inc. current report, Q4 FY2015

Current report, Q4 FY2015

Cocrystal Pharma, Inc. current report, Q4 FY2015

News

Why Cocrystal Pharma Shares Are Cooling Off Monday? - Cocrystal Pharma (NASDAQ:COCP)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Cocrystal begins dosing patients in norovirus challenge study

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma raises $4.7 million in registered direct offering

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study

H.C. Wainwright lowers Cocrystal Pharma stock price target on dilution